LITTLETON, Colo.--(BUSINESS WIRE)--Aug. 2, 2005--Zynex Medical Holdings, Inc. (OTCBB:ZYNX), a provider of pain management systems and electrotherapy products for medical patients with functional disability, today announced it has completed field testing of it’s new IF8100 inferential current (IFC) device that offers users a new set of treatment modalities for home use based on popular in-clinic parameters.
